Titre du document / Document title

Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002

Auteur(s) / Author(s)

The ESRD Incidence Study Group, NOUVELLE-ZELANDE
MCCREDIE Margaret ⁽¹⁾ ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Department of Preventive and Social Medicine, University of Otago, PO Box 913, Dunedin, NOUVELLE-ZELANDE

Résumé / Abstract

Aims To describe the variation in geographical distribution of end-stage renal disease (ESRD) due to Type 1 and Type 2 diabetes, and to calculate recent trends in incidence in predominantly white populations. Methods Estimation of age- and sex-standardized incidence of ESRD by type of diabetes, and temporal trends, in population-based data for persons aged 30-44, 45-54 or 55-64 years newly treated for ESRD during 1998-2002 in eight countries or regions of Europe, and Non-Indigenous Canadians and Australians. Results The incidence of ESRD due to Type 1 diabetes at age 30-44 years correlated with published rates of childhood-onset insulin dependent diabetes mellitus (P = 0.0025). ESRD due to Type 2 diabetes was uncommon before 45 years of age; in older persons, the highest rates (in Canada and Austria) were five times the lowest rates (in Norway and the Basque region). Rates of ESRD due to Type 1 diabetes fell, per year, by 6.4% [95% confidence interval (CI): 2.1-10.6%) in persons aged 30-44 years, and by 7.7% (95% CI: 2.4-12.7%] in those aged 45-54 years. In contrast, rates of ESRD due to Type 2 diabetes increased annually by 16% (95% CI: 5-28%) in the 30-44-year age group, 11% (95% CI: 6-16%) at 45-54 years, and 9% (95% CI: 5-14%) at 55-64 years. Conclusions Modern prevention has reduced progression of nephropathy to ESRD due to Type 1 diabetes, but the continuing rise of ESRD due to Type 2 diabetes represents a failure of current disease control measures that has serious public health implications.

Revue / Journal Title

Diabetic medicine   ISSN 0742-3071   CODEN DIMEEV 

Source / Source

2006, vol. 23, n^o12, pp. 1364-1369 [6 page(s) (article)] (26 ref.)

Langue / Language

Anglais

Editeur / Publisher

Blackwell, Oxford, ROYAUME-UNI  (1984) (Revue)

Mots-clés anglais / English Keywords

Metabolic diseases ; Immunopathology ; Autoimmune disease ; Endocrinopathy ; Kidney disease ; Urinary system disease ; Oceania ; America ; North America ; Australia ; Canada ; Type 2 diabetes ; Europe ; Public health ; Type 1 diabetes ; Epidemiology ; Incidence ; Renal failure ;

Mots-clés français / French Keywords

Métabolisme pathologie ; Immunopathologie ; Maladie autoimmune ; Endocrinopathie ; Rein pathologie ; Appareil urinaire pathologie ; Océanie ; Amérique ; Amérique du Nord ; Australie ; Canada ; Diabète type 2 ; Europe ; Santé publique ; Diabète type 1 ; Epidémiologie ; Incidence ; Insuffisance rénale ;

Mots-clés espagnols / Spanish Keywords

Metabolismo patología ; Inmunopatología ; Enfermedad autoinmune ; Endocrinopatía ; Riñón patología ; Aparato urinario patología ; Oceania ; America ; America del norte ; Australia ; Canadá ; Diabetes de tipo 2 ; Europa ; Salud pública ; Diabetes de tipo 1 ; Epidemiología ; Incidencia ; Insuficiencia renal ;

Mots-clés d'auteur / Author Keywords

end-stage renal disease ; incidence ; temporal trends ; Type 1 diabetes ; Type 2 diabetes ;

Localisation / Location

INIST-CNRS, Cote INIST : 20274, 35400015904320.0150